Redux

Redux is a diet drug that was approved for use by the Federal Drug Administration in 1996 and withdrawn on Sept. 15, 1997, after heart valve damage was detected in patients using the drug. During its one year on the market, Redux generated sales of $ 255.3 million. There have been 123 deaths related to use of Redux.

Lawsuits now pending allege that Redux is linked to heart-valve disease and an often fatal lung condition known as Primary Pulmonary Hypertension (PPH). About 6,000 lawsuits to date have been filed on behalf of 11,000 plaintiffs who took the diet drug. There is evidence that the dangers of the drug were well known before it was removed from the market. In 1995, while the drug was in the approval stage, the lead FDA medical officer reviewing Redux believed the drug had low effectiveness and very high risk for neurotoxicity and pulmonary hypertension.

The lawsuits also allege that the company failed to adequately disclose the risks of these conditions. American Home Products, the manufacturer of Redux, has contended it acted responsibly. In the wake of increasing litigation, however, American Home Products has agreed to pay or set aside $ 3.75 billion to settle lawsuits related to the drugs' potential to cause heart valve damage for the next 15 years. According to a Boston University School of Medicine study, almost 2 million former users have heart valve damage. So far, fewer than 500,000 users have received compensation from lawsuits. Click on Redux/Pondimin Settlement Agreement, to see the terms of the national settlement.

If you or a loved one is in need of legal assistance, call Lea, Rhine, Rosbrugh & Chleborowicz, P.L.L.C. at (910) 772-9960 or toll free at (866) 772-9960 or submit an online questionnaire. If we agree to handle your case, we will work on a contingency fee basis, which means we get paid for our services only if there is a monetary recovery of funds. In many cases, a lawsuit must be filed before an applicable expiration date, known as a statute of limitations. Please call right away to ensure that you do not waive your right to possible compensation.



More Information

Phen-Fen Pondimin Redux / Pondimin Settlement Agreement Phen-Fen Heart Valve Disease

Resources

Heart Info RxList PPH Newsletter
Copyright © 2006 Lea, Rhine, Rosbrugh & Chleborowicz – North Carolina personal injury attorneys, motor vehicle accident lawyers and product liability attorneys,
serving Wilmington, New Hanover county and cities throughout North Carolina. All rights reserved. MegaSites by MegaHunter - VLPC.

North Carolina Pharmaceutical Litigation Lawyers Disclaimer: The North Carolina pharmaceutical litigation, mass tort drug case, drug injury, personal injury and/or other legal information offered herein by Lea, Rhine, Rosbrugh & Chleborowicz, Wilmington Pharmaceutical Litigation Lawyers, is not formal legal advice nor the formation of an attorney client relationship. Any results set forth herein are based only upon the facts of that particular case and offer no promise or guarantee on the outcome of any case. This site is not intended to solicit clients outside the State of North Carolina.

Web Site Marketing by: SLS Consulting - Lawyer, Attorney, Law Firm and Legal Web Sites